QTTB FY 2024 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0+100.0% YoY

Gross Profit

-$487,000

Operating Income

-$66M

Net Income

-$48M

EPS (Diluted)

$-6.58

Cash Flow

Operating Cash Flow

-$68M

Free Cash Flow

-$68M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$92M

Total Liabilities

$87M

Stockholders' Equity

$6M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	-$7M	+100.0%
Gross Profit	-$487,000	-$7M	+92.7%
Operating Income	-$66M	-$48M	-37.0%
Net Income	-$48M	-$54M	+11.2%